DK0868188T3 - Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen - Google Patents

Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen

Info

Publication number
DK0868188T3
DK0868188T3 DK96946221T DK96946221T DK0868188T3 DK 0868188 T3 DK0868188 T3 DK 0868188T3 DK 96946221 T DK96946221 T DK 96946221T DK 96946221 T DK96946221 T DK 96946221T DK 0868188 T3 DK0868188 T3 DK 0868188T3
Authority
DK
Denmark
Prior art keywords
combination
contraception
progestogen
estrogen
kits
Prior art date
Application number
DK96946221T
Other languages
English (en)
Inventor
Jan Endrikat
Bernd Duesterberg
Pia Reilhac
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0868188T3 publication Critical patent/DK0868188T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK96946221T 1995-12-23 1996-12-20 Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen DK0868188T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19549264A DE19549264A1 (de) 1995-12-23 1995-12-23 Verfahren und Kit zur Kontrazeption
PCT/DE1996/002486 WO1997023228A2 (de) 1995-12-23 1996-12-20 Verfahren und kit zur kontrazeption bei weiblichen säugern, bestehend aus einer kombination von gestagen und estrogen

Publications (1)

Publication Number Publication Date
DK0868188T3 true DK0868188T3 (da) 2003-10-06

Family

ID=7781724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96946221T DK0868188T3 (da) 1995-12-23 1996-12-20 Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen

Country Status (23)

Country Link
US (1) US6995149B1 (da)
EP (1) EP0868188B1 (da)
JP (1) JP2000502108A (da)
KR (1) KR19990076685A (da)
AT (1) ATE244567T1 (da)
AU (1) AU716249B2 (da)
BR (1) BR9612207A (da)
CA (1) CA2241192A1 (da)
CZ (1) CZ291743B6 (da)
DE (2) DE19549264A1 (da)
DK (1) DK0868188T3 (da)
ES (1) ES2202498T3 (da)
HU (1) HUP9901662A3 (da)
IL (1) IL124472A (da)
IS (1) IS4753A (da)
MX (1) MX9804395A (da)
NO (1) NO982902D0 (da)
NZ (1) NZ330741A (da)
PL (1) PL187180B1 (da)
PT (1) PT868188E (da)
SK (1) SK79298A3 (da)
UA (1) UA59356C2 (da)
WO (1) WO1997023228A2 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
CN1270521A (zh) * 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/***并且第二阶段包含孕激素的口服避孕制剂
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
ES2734510T3 (es) * 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
ES2795455T3 (es) * 2008-10-08 2020-11-23 Agile Therapeutics Inc Suministro transdérmico
US9192614B2 (en) * 2008-10-08 2015-11-24 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CA2756222A1 (en) * 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
WO2012096411A1 (ja) * 2011-01-12 2012-07-19 国立大学法人宮崎大学 難治性炎症性腸疾患の予防又は治療方法
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
NZ311304A (en) * 1995-06-07 1999-03-29 Cygnus Therapeutic Systems Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
JP2003527820A (ja) * 1998-08-17 2003-09-24 ザ ステート オブ オレゴン アクティング バイ アンド スルー ザ ステート ボード オブ ハイアー エデュケーション オン ビハーフ オブ ザ ユニバーシティー オブ オレゴン 概日時計機能及び光周性を制御する遺伝子

Also Published As

Publication number Publication date
NZ330741A (en) 2000-03-27
IL124472A (en) 2001-07-24
WO1997023228A2 (de) 1997-07-03
ES2202498T3 (es) 2004-04-01
JP2000502108A (ja) 2000-02-22
SK79298A3 (en) 2000-06-12
AU1921997A (en) 1997-07-17
AU716249B2 (en) 2000-02-24
ATE244567T1 (de) 2003-07-15
US6995149B1 (en) 2006-02-07
EP0868188A2 (de) 1998-10-07
CA2241192A1 (en) 1997-07-03
DE59610600D1 (de) 2003-08-14
IS4753A (is) 1998-05-22
DE19549264A1 (de) 1997-06-26
PL187180B1 (pl) 2004-05-31
CZ9802000A3 (cs) 1998-11-11
HUP9901662A3 (en) 1999-11-29
KR19990076685A (ko) 1999-10-15
MX9804395A (es) 1998-09-30
PL327182A1 (en) 1998-11-23
UA59356C2 (uk) 2003-09-15
CZ291743B6 (cs) 2003-05-14
EP0868188B1 (de) 2003-07-09
NO982902L (no) 1998-06-22
WO1997023228A3 (de) 1997-08-28
BR9612207A (pt) 1999-07-13
HUP9901662A2 (hu) 1999-09-28
IL124472A0 (en) 1998-12-06
PT868188E (pt) 2003-11-28
NO982902D0 (no) 1998-06-22

Similar Documents

Publication Publication Date Title
DK0868188T3 (da) Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
NO845194L (no) Flertrinnskombinasjonspreparat og anvendelse av dette som oralt antikonsepsjonsmiddel
ES2087964T3 (es) Contraceptivos orales bajos en estrogenos.
NO976067D0 (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
FI98984B (fi) Ehkäisyvalmiste, joka sisältää ainoastaan progestogeenia
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
ATE91410T1 (de) Osmotische dosierungsform.
GR1001395B (el) Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.